240 related articles for article (PubMed ID: 28692584)
1. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening.
Hübner J; Waldmann A; Eisemann N; Noftz M; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A
Eur J Cancer Prev; 2018 Nov; 27(6):563-569. PubMed ID: 28692584
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
Schmitt J; Seidler A; Heinisch G; Sebastian G
J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
[TBL] [Abstract][Full Text] [Related]
3. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.
Waldmann A; Nolte S; Weinstock MA; Breitbart EW; Eisemann N; Geller AC; Greinert R; Volkmer B; Katalinic A
Br J Cancer; 2012 Feb; 106(5):970-4. PubMed ID: 22294187
[TBL] [Abstract][Full Text] [Related]
4. Systematic skin cancer screening in Northern Germany.
Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A
J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699
[TBL] [Abstract][Full Text] [Related]
5. Observed and expected mortality in the German skin cancer screening pilot project SCREEN.
Eisemann N; Waldmann A; Holleczek B; Katalinic A
J Med Screen; 2018 Sep; 25(3):166-168. PubMed ID: 29169295
[TBL] [Abstract][Full Text] [Related]
6. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
Stang A; Jöckel KH; Heidinger O
Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
[TBL] [Abstract][Full Text] [Related]
7. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.
Hübner J; Waldmann A; Geller AC; Weinstock MA; Eisemann N; Noftz M; Bertram S; Nolte S; Volkmer B; Greinert R; Breitbart E; Katalinic A
Br J Cancer; 2017 Jan; 116(2):253-259. PubMed ID: 27898656
[TBL] [Abstract][Full Text] [Related]
8. Melanoma mortality following skin cancer screening in Germany.
Boniol M; Autier P; Gandini S
BMJ Open; 2015 Sep; 5(9):e008158. PubMed ID: 26373399
[TBL] [Abstract][Full Text] [Related]
9. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
10. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations.
Waldmann A; Nolte S; Geller AC; Katalinic A; Weinstock MA; Volkmer B; Greinert R; Breitbart EW
Arch Dermatol; 2012 Aug; 148(8):903-10. PubMed ID: 22911184
[TBL] [Abstract][Full Text] [Related]
11. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
Stang A; Jöckel KH
Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
[TBL] [Abstract][Full Text] [Related]
12. Total-Body Examination vs Lesion-Directed Skin Cancer Screening.
Hoorens I; Vossaert K; Pil L; Boone B; De Schepper S; Ongenae K; Annemans L; Chevolet I; Brochez L
JAMA Dermatol; 2016 Jan; 152(1):27-34. PubMed ID: 26466155
[TBL] [Abstract][Full Text] [Related]
13. Melanoma screening: A plan for improving early detection.
Shellenberger R; Nabhan M; Kakaraparthi S
Ann Med; 2016; 48(3):142-8. PubMed ID: 26911192
[TBL] [Abstract][Full Text] [Related]
14. Solar elastosis and cutaneous melanoma: a site-specific analysis.
Kvaskoff M; Pandeya N; Green AC; Perry S; Baxter C; Davis MB; Mortimore R; Westacott L; Wood D; Triscott J; Williamson R; Whiteman DC
Int J Cancer; 2015 Jun; 136(12):2900-11. PubMed ID: 25403328
[TBL] [Abstract][Full Text] [Related]
15. Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies.
Seidenari S; Benati E; Ponti G; Borsari S; Ferrari C; Albertini G; Altomare G; Arcangeli F; Aste N; Bernengo MG; Bongiorno MR; Borroni G; Calvieri S; Chimenti S; Cusano F; Fracchiolla C; Gaddoni G; Girolomoni G; Guarneri B; Lanzoni A; Lombardi M; Lotti T; Mariotti A; Marsili F; Micali G; Parodi A; Peris K; Peserico A; Quaglino P; Santini M; Schiavon S; Tonino C; Trevisan G; Tribuzi P; Valentini P; Vena GA; Virgili A
Eur J Cancer Prev; 2012 Jan; 21(1):89-95. PubMed ID: 22001916
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study.
Watts CG; Madronio C; Morton RL; Goumas C; Armstrong BK; Curtin A; Menzies SW; Mann GJ; Thompson JF; Cust AE
JAMA Dermatol; 2017 Jan; 153(1):23-29. PubMed ID: 27829101
[TBL] [Abstract][Full Text] [Related]
17. Supply-and-demand discrepancy in academic pigmented lesion clinics: a case for a new health care delivery model.
Vickery EL; Seidler EM; Jones TE; Veledar E; Chen SC
JAMA Dermatol; 2014 Nov; 150(11):1167-72. PubMed ID: 25028988
[TBL] [Abstract][Full Text] [Related]
18. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].
Eisemann N; Waldmann A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):77-83. PubMed ID: 24357176
[TBL] [Abstract][Full Text] [Related]
19. [Screening for and early detection of skin melanoma in the Netherlands].
van Roekel EH; Verbeek AL; Bonenkamp H
Ned Tijdschr Geneeskd; 2012; 156(26):A4456. PubMed ID: 22759708
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]